Trade Omnicell Inc - OMCL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.14 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 31.15 |
| Open | 30.7 |
| 1-Year Change | 11.88% |
| Day's Range | 30.47 - 31.1 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 30.88 | 0.23 | 0.75% | 30.65 | 31.13 | 30.45 |
| Apr 24, 2025 | 31.15 | 0.49 | 1.60% | 30.66 | 31.21 | 30.30 |
| Apr 23, 2025 | 30.61 | 0.35 | 1.16% | 30.26 | 31.50 | 30.26 |
| Apr 22, 2025 | 29.88 | 0.53 | 1.81% | 29.35 | 30.13 | 29.35 |
| Apr 21, 2025 | 29.58 | -0.37 | -1.24% | 29.95 | 30.20 | 29.25 |
| Apr 17, 2025 | 30.22 | -0.07 | -0.23% | 30.29 | 30.77 | 30.03 |
| Apr 16, 2025 | 30.88 | -0.10 | -0.32% | 30.98 | 31.32 | 30.60 |
| Apr 15, 2025 | 31.27 | -0.01 | -0.03% | 31.28 | 31.70 | 30.90 |
| Apr 14, 2025 | 31.54 | 0.55 | 1.77% | 30.99 | 31.73 | 30.84 |
| Apr 11, 2025 | 31.13 | 1.13 | 3.77% | 30.00 | 31.34 | 30.00 |
| Apr 10, 2025 | 31.02 | -0.41 | -1.30% | 31.43 | 31.98 | 30.63 |
| Apr 9, 2025 | 32.65 | 3.43 | 11.74% | 29.22 | 32.86 | 29.22 |
| Apr 8, 2025 | 30.45 | -1.72 | -5.35% | 32.17 | 32.42 | 29.85 |
| Apr 7, 2025 | 31.51 | 0.30 | 0.96% | 31.21 | 33.05 | 30.07 |
| Apr 4, 2025 | 32.58 | -1.47 | -4.32% | 34.05 | 34.05 | 31.31 |
| Apr 3, 2025 | 33.96 | 0.93 | 2.82% | 33.03 | 34.37 | 33.03 |
| Apr 2, 2025 | 35.37 | 1.51 | 4.46% | 33.86 | 35.43 | 33.86 |
| Apr 1, 2025 | 35.21 | 0.76 | 2.21% | 34.45 | 35.88 | 33.95 |
| Mar 31, 2025 | 34.90 | 1.08 | 3.19% | 33.82 | 35.03 | 33.82 |
| Mar 28, 2025 | 34.94 | 1.10 | 3.25% | 33.84 | 35.13 | 33.84 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Omnicell Company profile
About Omnicell, Inc.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Omnicell, Inc. revenues increased 27% to $1.13B. Net income increased from $32.2M to $77.8M. Revenues reflect Connected devices, software licenses, and other segment increase of 32% to $739.1M, SaaS, subscription software, and technology-enabled services segment increase from $53.8M to $112.5M, United States segment increase of 28% to $1.02B, Rest of the World segment increase of 18% to $111.2M.
Equity composition
Common Stock $.001 Par, 12/10, 100M auth., 37,148,706 issd. 4,121,123 shs. in Treas. @$65.1M. Insiders own 2.25%. Initial Public Offering: 8/07/01, 6Mshares @ $7 by U.S. Bancorp Piper Jaffray. 7/01 1-for-1.6 stock split. *NOTE: 8/01, the Company changed it's name from Omnicell.com.
| Industry: | Medical Software & Technology Services |
4220 North Freeway
FORT WORTH
TEXAS 76137
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com